Three complementary liquid chromatographic methods for determination of the peptoid cholecystokinin-B antagonist, CI-988, in rat plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 14, Issue 7, 1996, Pages 815-824

  Hinton, Joanna P ^a   Pablo, Julius C ^a   Bjorge, Susan M ^a,b   Hoffman, Keith ^a   Jennings, Kathleen ^a   Wright, D Scott ^a  

^a PFIZER INC   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

Assay validation; Bioanalytical method; Cholecystokinin B antagonist; CI 988; Correlation; Liquid chromatography; Specificity

Indexed keywords

4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; CHOLECYSTOKININ B RECEPTOR ANTAGONIST;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RAT;

EID: 0029975204     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0731-7085(95)01686-4     Document Type: Article

References (18)

1. V.P. Shah, K.K., Midha, S. Dighe, I.J. McGilveray, J.P. Skelly, A. Yacobi, T. Layloff, C.T. Viswanathan, C.E. Cook, R.D. McDowall, K.A. Pittman and S. Spector, J. Pharm. Sci., 81 (1992) 309-312.
2. L.A. Pachla, D.S. Wright and D.L. Reynolds, J. Clin. Pharmacol., 26 (1986) 332-335.
3. H.T. Karnes, G. Shiu and V.P. Shah, Pharm. Res., 8(4) (1991) 421-426.
4. D. Dadgar, P.E. Burnett, M.G. Choc, K. Gallicano and J.W. Harper, J. Pharm. Biomed. Anal., 13 (1995) 89-97.
5. J. Kirschbaum, S. Perlman, J. Joseph and J. Adamovics, J. Chromatogr. Sci., 22 (1984) 27-30.
6. E. Gelpi, Life Sci., 41 (1987) 849-852.
7. L.R. Snyder and J.J. Kirkland, Introduction to Modern Liquid Chromatography, 2nd edn., John Wiley, New York, 1979, pp. 591-614.
8. J. Hughes, P. Boden, B. Costall, A. Domeney, E. Kelly, D.C. Horwell, J.C. Hunter, R.D. Pinnock and G.N. Woodruff, Proc. Natl. Acad. Sci. U.S.A., 87 (1990) 6728-6732.
9. G.N. Woodruff, D.R. Hill, P. Boden, R. Pinnock, L. Singh and J. Hughes, Neuropeptides, 19 (1991) 45-56.
10. L. Singh, A.S. Lewis, M.J. Field, J. Hughes and G.N. Woodruff, Proc. Nat. Acad. Sci. U.S.A., 88 (1991) 1130-1133.
11. J. Hughes, J.C. Hunter and G.N. Woodruff, Neuropeptides, 19 (1991) 85-89.
12. L. Singh, M.J. Field, J. Hughes, R. Menzies, R.J. Oles, C.A. Vass and G.N. Woodruff, Br. J. Pharmacol., 104 (1991) 239-245.
13. K.R. Powell and J.E. Barren, Neuropeptides, 19 (1991) 75-78.
14. J. Bradwejn, D. Koszycki, M. Paradis, P. Reece, J. Hinton and A. Sedman, Biol. Psychiatry, 38 (1995) 742-746.
15. J.P. Hinton, K. Jennings, E.L. Johnson and D.S. Wright, Biomed. Chromatogr., 9 (1995) 94-97.
16. A.S. Kearney, S.C. Mehta and G.W. Radebaugh, Pharm. Res., 9 (1992) 1092-1095.
17. L.R. Snyder, J.L. Glajch and J.J. Kirkland, Practical HPLC Method Development, John Wiley, New York, 1988, pp. 100-114, 126-130.
18. H.A. Strobel and W.R. Heineman, Chemical Instrumentation: A Systematic Approach, 3rd edn., John Wiley, New York, 1989, p. 355.